IBDEI22J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1826,0)
 ;;=FOLLOW-UP^2^164
 ;;^UTILITY(U,$J,358.4,1827,0)
 ;;=CONSULTATIONS^1^164
 ;;^UTILITY(U,$J,358.4,1828,0)
 ;;=NURSING^4^164
 ;;^UTILITY(U,$J,358.4,1829,0)
 ;;=NEW PATIENT^3^164
 ;;^UTILITY(U,$J,358.4,1830,0)
 ;;=TREATMENT PLANNING^10^165
 ;;^UTILITY(U,$J,358.4,1831,0)
 ;;=SIMULATION^5^165
 ;;^UTILITY(U,$J,358.4,1832,0)
 ;;=TREATMENT DEVICES^9^165
 ;;^UTILITY(U,$J,358.4,1833,0)
 ;;=DOSIMETRY CALCULATIONS^2^165
 ;;^UTILITY(U,$J,358.4,1834,0)
 ;;=TELETHERAPY ISODOSE PLAN^7^165
 ;;^UTILITY(U,$J,358.4,1835,0)
 ;;=WEEKLY TX MANAGEMENT^11^165
 ;;^UTILITY(U,$J,358.4,1836,0)
 ;;=MISCELLANEOUS^4^165
 ;;^UTILITY(U,$J,358.4,1837,0)
 ;;=IMRT PLAN^3^165
 ;;^UTILITY(U,$J,358.4,1838,0)
 ;;=TREATMENT DELIVERY^8^165
 ;;^UTILITY(U,$J,358.4,1839,0)
 ;;=BRACHYTHERAPY ISODOSE PLAN^1^165
 ;;^UTILITY(U,$J,358.4,1840,0)
 ;;=STEREOTACTIC TREATMENT^6^165
 ;;^UTILITY(U,$J,358.4,1841,0)
 ;;=EDUCATION/TRAINING^1^166
 ;;^UTILITY(U,$J,358.4,1842,0)
 ;;=PROCEDURE CODES-GROUP^3^166
 ;;^UTILITY(U,$J,358.4,1843,0)
 ;;=SPECIALTY GRP PROCEDURES^4^166
 ;;^UTILITY(U,$J,358.4,1844,0)
 ;;=FAMILY TRAINING-GROUP^2^166
 ;;^UTILITY(U,$J,358.4,1845,0)
 ;;=RECREATION THERAPY DIAGNOSES^1^167
 ;;^UTILITY(U,$J,358.4,1846,0)
 ;;=Primary Diagnosis for RCAT Therapy^1^168
 ;;^UTILITY(U,$J,358.4,1847,0)
 ;;=1-1 THERAPEUTIC PROCEDURES^1^169
 ;;^UTILITY(U,$J,358.4,1848,0)
 ;;=EDUCATION/TRAINING^3^169
 ;;^UTILITY(U,$J,358.4,1849,0)
 ;;=TEAM CONFERENCE^6^169
 ;;^UTILITY(U,$J,358.4,1850,0)
 ;;=ASSESSMENT^2^169
 ;;^UTILITY(U,$J,358.4,1851,0)
 ;;=FAMILY TRAINING^4^169
 ;;^UTILITY(U,$J,358.4,1852,0)
 ;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^169
 ;;^UTILITY(U,$J,358.4,1853,0)
 ;;=Primary Diagnosis for RCAT Therapy^1^170
 ;;^UTILITY(U,$J,358.4,1854,0)
 ;;=RECREATION THERAPY DIAGNOSES^1^171
 ;;^UTILITY(U,$J,358.4,1855,0)
 ;;=NEW PATIENT^2^172
 ;;^UTILITY(U,$J,358.4,1856,0)
 ;;=ESTABLISHED PATIENT^1^172
 ;;^UTILITY(U,$J,358.4,1857,0)
 ;;=CONSULTATIONS^3^172
 ;;^UTILITY(U,$J,358.4,1858,0)
 ;;=THERAPY MODALITIES/PROCEDURES^12^173
 ;;^UTILITY(U,$J,358.4,1859,0)
 ;;=INJECTIONS/DRUGS^5^173
 ;;^UTILITY(U,$J,358.4,1860,0)
 ;;=ORTHOTIC DEVICES^8^173
 ;;^UTILITY(U,$J,358.4,1861,0)
 ;;=KINESIOTHERAPY^6^173
 ;;^UTILITY(U,$J,358.4,1862,0)
 ;;=THERAPY EVALUATIONS^11^173
 ;;^UTILITY(U,$J,358.4,1863,0)
 ;;=WOUND CARE^13^173
 ;;^UTILITY(U,$J,358.4,1864,0)
 ;;=CARDIAC REHAB^1^173
 ;;^UTILITY(U,$J,358.4,1865,0)
 ;;=EDUCATION/TRAINING^2^173
 ;;^UTILITY(U,$J,358.4,1866,0)
 ;;=HOME THERAPY SERVICES^4^173
 ;;^UTILITY(U,$J,358.4,1867,0)
 ;;=NEUROMUSCULAR TESTING^7^173
 ;;^UTILITY(U,$J,358.4,1868,0)
 ;;=TEAM CONFERENCE^10^173
 ;;^UTILITY(U,$J,358.4,1869,0)
 ;;=HEALTH BEHAVIORS^3^173
 ;;^UTILITY(U,$J,358.4,1870,0)
 ;;=RECREATION THERAPY^9^173
 ;;^UTILITY(U,$J,358.4,1871,0)
 ;;=PRIMARY DIAGNOSES^1^174
 ;;^UTILITY(U,$J,358.4,1872,0)
 ;;=V CODES ^11^175
 ;;^UTILITY(U,$J,358.4,1873,0)
 ;;=AMPUTATION STATUS^1^175
 ;;^UTILITY(U,$J,358.4,1874,0)
 ;;=BRAIN DISORDERS^2^175
 ;;^UTILITY(U,$J,358.4,1875,0)
 ;;=CARDIOPULMONARY^3^175
 ;;^UTILITY(U,$J,358.4,1876,0)
 ;;=COMPLICATION DUE TO^4^175
 ;;^UTILITY(U,$J,358.4,1877,0)
 ;;=FRACTURES-LATE EFFECTS^5^175
 ;;^UTILITY(U,$J,358.4,1878,0)
 ;;=MENTAL DISORDERS^6^175
 ;;^UTILITY(U,$J,358.4,1879,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^7^175
 ;;^UTILITY(U,$J,358.4,1880,0)
 ;;=TERTIARY DX-TBI CODES^10^175
 ;;^UTILITY(U,$J,358.4,1881,0)
 ;;=QUATERNARY DX-POLYTRAUMA/TBI V-CODE^9^175
 ;;^UTILITY(U,$J,358.4,1882,0)
 ;;=PHYSICAL^8^175
 ;;^UTILITY(U,$J,358.4,1883,0)
 ;;=HEAD/CEREBRAL^4^176
 ;;^UTILITY(U,$J,358.4,1884,0)
 ;;=CERVICAL SPINE^1^176
 ;;
 ;;$END ROU IBDEI22J
